New Drug Product: Imbruvica

Treatment of patients with mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.

Depression in Cancer Patients

Patients with cancer and depression frequently do not receive effective treatment.

Diabetes Risk for Lymphoma Survivors

Para-aortic radiation correlates with increased diabetes mellitus risk for Hodgkin's lymphoma survivors.

Colonic Diverticular Disease, Cancer

Colonic diverticular disease does not appear to be linked to an increased risk of subsequent colorectal cancer.

Botulinum Toxin as Cancer Treatment?

The therapeutic effects of systemic chemotherapy were enhanced by vagotomy or botulinum toxin type A treatment in a study.

Active Surveillance for Testicular Cancer

Active surveillance for clinical stage I (CSI) testis cancer leads to excellent outcomes.

NSAIDs, Breast Cancer Recurrence

Daily use of NSAIDs may reduce the recurrence rate of hormone-responsive breast cancer in overweight or obese women.

Prostate Cancer Treatments

Review this new chart on FDA-approved prostate cancer treatments for quick information when you need it.

News

E-Cigarettes Don't Help Cancer Patients Quit Smoking

E-Cigarettes Don't Help Cancer Patients Quit Smoking

Smokers with cancer who used e-cigarettes along with traditional cigarettes were more dependent on nicotine than those who didn't use the devices, and were just as likely - or less likely - to have quit smoking than patients who didn't use e-cigarettes.

Tumor Vulnerability Varies with Clonal Evolution in Acute Lymphoblastic Leukemia

Tumor Vulnerability Varies with Clonal Evolution in Acute Lymphoblastic Leukemia

In acute lymphoblastic leukemia (ALL), tumor vulnerability to different chemotherapeutic agents varies at different stages of clonal evolution, which could represent a viable strategy in avoiding drug resistance.

DPP-4 Inhibitors: Pancreatic Cancer Risk Not Higher

DPP-4 Inhibitors: Pancreatic Cancer Risk Not Higher

There is no increased short-term pancreatic cancer risk with dipeptidyl-peptidase-4 inhibitors (DPP-4i) compared to sulfonylureas (SU) and thiazolidinediones (TZD) for glycemic control.

Blinatumomab BLA Submitted for Acute Lymphoblastic Leukemia

Blinatumomab BLA Submitted for Acute Lymphoblastic Leukemia

Amgen announced that it has submitted a Biologics License Application (BLA) to the Food and Drug Administration (FDA) for blinatumomab for the treatment of Philadelphia-negative (Ph-) relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL).

Family Conflict Can Derail Cancer Surgery Recovery

Family Conflict Can Derail Cancer Surgery Recovery

Cancer patients burdened by stress and family conflicts before surgery may face a higher risk for complications following their operation.

Charts

Make prescribing decisions with our comparative charts and treatment algorithms.

Calculators

Quickly and accurately perform clinical calculations.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Featured courses from mycme

The Brigham Board Review in Hematology and OncologyExternal web site

The Brigham Board Review in Hematology and Oncology offers expert preparation for your ABIM subspecialty ...

CME 42.00 Credits

Comprehensive Review of Radiation OncologyExternal web site

Radiation oncologists and residents will appreciate the experience of the renowned faculty of the Comprehensive ...

CME 23.00 Credits

Understanding Current and Emerging Therapies for Head and Neck CancersExternal web site

This activity can help oncology nurses refresh their knowledge of the risks and treatments for ...

CE 0.50 Credits

Sign Up for Free e-newsletters